Review



brdu elisa kit  (Servicebio Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 86
      Buy from Supplier

    Structured Review

    Servicebio Inc brdu elisa kit
    Targeted repair of hypoxia/reoxygenation (H/R)-injured lung epithelial cells by Rg3@PACVs (A) Cellular uptake of Dio-labeled Rg3@PACVs (green) by H/R-injured BEAS-2B cells. Fluorescent localization was analyzed with or without pretreatment of endocytosis inhibitors (filipin, chlorpromazine, or chloroquine) (scale bars, 20 μm). (B–E) Cytokine adsorption capacity assessed by co-incubation of Rg3@PACVs (500 or 250 μg/mL) with inflammatory cytokines (IL-6, TNF-α, IL-1β, and CCL-2). Cytokine concentrations in supernatants were measured after centrifugation ( ∗∗∗ p < 0.001 vs. 0 μg/mL; # p < 0.05, ## p < 0.01 vs. 250 μg/mL; n = 3 biological replicates). (F) Cell viability of H/R-treated BEAS-2B cells assessed by cell counting kit-8 (CCK-8) assay. Cells were treated with Rg3, PACVs, or Rg3@PACVs with or without near-infrared (NIR) irradiation. (G–I) Real-time quantitative polymerase chain reaction (RT-qPCR) analysis of inflammatory gene expression (IL-6, IL-1β, and TNF-α) in H/R-stimulated BEAS-2B cells under different pretreatment conditions. (J) Immunofluorescence showing expression and co-localization of NLRP3 (green) and COX2 (red) in H/R-injured lung epithelial cells. Nuclei stained with DAPI (blue). Scale bars, 100 μm. (K) Cell proliferation detected by bromodeoxyuridine <t>(BrdU)</t> staining (red) in the above epithelial cells. Nuclei stained with DAPI (blue). Scale bars, 50 μm. (L) Apoptosis ratio analyzed by flow cytometry using Annexin V-Allophycocyanin (Annexin V-APC) and 7-Aminoactinomycin D (7-AAD) staining. Data are presented as the mean ± SD and analyzed using one-way ANOVA (B–E and G–I) and two-way ANOVA (F) with Tukey’s post hoc test (∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001 vs. control; # p < 0.05, ## p < 0.01, ### p < 0.001 vs. H/R; & p < 0.05, && p < 0.01, &&& p < 0.001 vs. H/R + Rg3@PACVs; n = 3 biological replicates, for F–I).
    Brdu Elisa Kit, supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/brdu+elisa+kit/pmc13198320-60-0-4?v=Servicebio+Inc
    Average 86 stars, based on 1 article reviews
    brdu elisa kit - by Bioz Stars, 2026-07
    86/100 stars

    Images

    1) Product Images from "Macrophage-mimetic photothermal nanotherapeutics regulate mitochondrial homeostasis and inflammatory cascades in lung ischemia-reperfusion injury"

    Article Title: Macrophage-mimetic photothermal nanotherapeutics regulate mitochondrial homeostasis and inflammatory cascades in lung ischemia-reperfusion injury

    Journal: Cell Reports Medicine

    doi: 10.1016/j.xcrm.2026.102768

    Targeted repair of hypoxia/reoxygenation (H/R)-injured lung epithelial cells by Rg3@PACVs (A) Cellular uptake of Dio-labeled Rg3@PACVs (green) by H/R-injured BEAS-2B cells. Fluorescent localization was analyzed with or without pretreatment of endocytosis inhibitors (filipin, chlorpromazine, or chloroquine) (scale bars, 20 μm). (B–E) Cytokine adsorption capacity assessed by co-incubation of Rg3@PACVs (500 or 250 μg/mL) with inflammatory cytokines (IL-6, TNF-α, IL-1β, and CCL-2). Cytokine concentrations in supernatants were measured after centrifugation ( ∗∗∗ p < 0.001 vs. 0 μg/mL; # p < 0.05, ## p < 0.01 vs. 250 μg/mL; n = 3 biological replicates). (F) Cell viability of H/R-treated BEAS-2B cells assessed by cell counting kit-8 (CCK-8) assay. Cells were treated with Rg3, PACVs, or Rg3@PACVs with or without near-infrared (NIR) irradiation. (G–I) Real-time quantitative polymerase chain reaction (RT-qPCR) analysis of inflammatory gene expression (IL-6, IL-1β, and TNF-α) in H/R-stimulated BEAS-2B cells under different pretreatment conditions. (J) Immunofluorescence showing expression and co-localization of NLRP3 (green) and COX2 (red) in H/R-injured lung epithelial cells. Nuclei stained with DAPI (blue). Scale bars, 100 μm. (K) Cell proliferation detected by bromodeoxyuridine (BrdU) staining (red) in the above epithelial cells. Nuclei stained with DAPI (blue). Scale bars, 50 μm. (L) Apoptosis ratio analyzed by flow cytometry using Annexin V-Allophycocyanin (Annexin V-APC) and 7-Aminoactinomycin D (7-AAD) staining. Data are presented as the mean ± SD and analyzed using one-way ANOVA (B–E and G–I) and two-way ANOVA (F) with Tukey’s post hoc test (∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001 vs. control; # p < 0.05, ## p < 0.01, ### p < 0.001 vs. H/R; & p < 0.05, && p < 0.01, &&& p < 0.001 vs. H/R + Rg3@PACVs; n = 3 biological replicates, for F–I).
    Figure Legend Snippet: Targeted repair of hypoxia/reoxygenation (H/R)-injured lung epithelial cells by Rg3@PACVs (A) Cellular uptake of Dio-labeled Rg3@PACVs (green) by H/R-injured BEAS-2B cells. Fluorescent localization was analyzed with or without pretreatment of endocytosis inhibitors (filipin, chlorpromazine, or chloroquine) (scale bars, 20 μm). (B–E) Cytokine adsorption capacity assessed by co-incubation of Rg3@PACVs (500 or 250 μg/mL) with inflammatory cytokines (IL-6, TNF-α, IL-1β, and CCL-2). Cytokine concentrations in supernatants were measured after centrifugation ( ∗∗∗ p < 0.001 vs. 0 μg/mL; # p < 0.05, ## p < 0.01 vs. 250 μg/mL; n = 3 biological replicates). (F) Cell viability of H/R-treated BEAS-2B cells assessed by cell counting kit-8 (CCK-8) assay. Cells were treated with Rg3, PACVs, or Rg3@PACVs with or without near-infrared (NIR) irradiation. (G–I) Real-time quantitative polymerase chain reaction (RT-qPCR) analysis of inflammatory gene expression (IL-6, IL-1β, and TNF-α) in H/R-stimulated BEAS-2B cells under different pretreatment conditions. (J) Immunofluorescence showing expression and co-localization of NLRP3 (green) and COX2 (red) in H/R-injured lung epithelial cells. Nuclei stained with DAPI (blue). Scale bars, 100 μm. (K) Cell proliferation detected by bromodeoxyuridine (BrdU) staining (red) in the above epithelial cells. Nuclei stained with DAPI (blue). Scale bars, 50 μm. (L) Apoptosis ratio analyzed by flow cytometry using Annexin V-Allophycocyanin (Annexin V-APC) and 7-Aminoactinomycin D (7-AAD) staining. Data are presented as the mean ± SD and analyzed using one-way ANOVA (B–E and G–I) and two-way ANOVA (F) with Tukey’s post hoc test (∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001 vs. control; # p < 0.05, ## p < 0.01, ### p < 0.001 vs. H/R; & p < 0.05, && p < 0.01, &&& p < 0.001 vs. H/R + Rg3@PACVs; n = 3 biological replicates, for F–I).

    Techniques Used: Labeling, Adsorption, Incubation, Centrifugation, Cell Counting, CCK-8 Assay, Irradiation, Real-time Polymerase Chain Reaction, Quantitative RT-PCR, Gene Expression, Immunofluorescence, Expressing, Staining, BrdU Staining, Flow Cytometry, Control



    Similar Products

    brdu cell proliferation elisa kit (colorimetric) ab126556  (Advisains)
    99
    Advisains brdu cell proliferation elisa kit (colorimetric) ab126556
    Brdu Cell Proliferation Elisa Kit (Colorimetric) Ab126556, supplied by Advisains, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/brdu+elisa+kit/advisains___ab126556?v=Advisains
    Average 99 stars, based on 1 article reviews
    brdu cell proliferation elisa kit (colorimetric) ab126556 - by Bioz Stars, 2026-07
    99/100 stars
    		  Buy from Supplier
    brdu elisa kit  (Servicebio Inc)
    86
    Servicebio Inc brdu elisa kit
    Targeted repair of hypoxia/reoxygenation (H/R)-injured lung epithelial cells by Rg3@PACVs (A) Cellular uptake of Dio-labeled Rg3@PACVs (green) by H/R-injured BEAS-2B cells. Fluorescent localization was analyzed with or without pretreatment of endocytosis inhibitors (filipin, chlorpromazine, or chloroquine) (scale bars, 20 μm). (B–E) Cytokine adsorption capacity assessed by co-incubation of Rg3@PACVs (500 or 250 μg/mL) with inflammatory cytokines (IL-6, TNF-α, IL-1β, and CCL-2). Cytokine concentrations in supernatants were measured after centrifugation ( ∗∗∗ p < 0.001 vs. 0 μg/mL; # p < 0.05, ## p < 0.01 vs. 250 μg/mL; n = 3 biological replicates). (F) Cell viability of H/R-treated BEAS-2B cells assessed by cell counting kit-8 (CCK-8) assay. Cells were treated with Rg3, PACVs, or Rg3@PACVs with or without near-infrared (NIR) irradiation. (G–I) Real-time quantitative polymerase chain reaction (RT-qPCR) analysis of inflammatory gene expression (IL-6, IL-1β, and TNF-α) in H/R-stimulated BEAS-2B cells under different pretreatment conditions. (J) Immunofluorescence showing expression and co-localization of NLRP3 (green) and COX2 (red) in H/R-injured lung epithelial cells. Nuclei stained with DAPI (blue). Scale bars, 100 μm. (K) Cell proliferation detected by bromodeoxyuridine <t>(BrdU)</t> staining (red) in the above epithelial cells. Nuclei stained with DAPI (blue). Scale bars, 50 μm. (L) Apoptosis ratio analyzed by flow cytometry using Annexin V-Allophycocyanin (Annexin V-APC) and 7-Aminoactinomycin D (7-AAD) staining. Data are presented as the mean ± SD and analyzed using one-way ANOVA (B–E and G–I) and two-way ANOVA (F) with Tukey’s post hoc test (∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001 vs. control; # p < 0.05, ## p < 0.01, ### p < 0.001 vs. H/R; & p < 0.05, && p < 0.01, &&& p < 0.001 vs. H/R + Rg3@PACVs; n = 3 biological replicates, for F–I).
    Brdu Elisa Kit, supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/brdu+elisa+kit/pmc13198320-60-0-4?v=Servicebio+Inc
    Average 86 stars, based on 1 article reviews
    brdu elisa kit - by Bioz Stars, 2026-07
    86/100 stars
    		  Buy from Supplier
    rc112 brdu elisa kit servicebio  (Servicebio Inc)
    86
    Servicebio Inc rc112 brdu elisa kit servicebio
    Targeted repair of hypoxia/reoxygenation (H/R)-injured lung epithelial cells by Rg3@PACVs (A) Cellular uptake of Dio-labeled Rg3@PACVs (green) by H/R-injured BEAS-2B cells. Fluorescent localization was analyzed with or without pretreatment of endocytosis inhibitors (filipin, chlorpromazine, or chloroquine) (scale bars, 20 μm). (B–E) Cytokine adsorption capacity assessed by co-incubation of Rg3@PACVs (500 or 250 μg/mL) with inflammatory cytokines (IL-6, TNF-α, IL-1β, and CCL-2). Cytokine concentrations in supernatants were measured after centrifugation ( ∗∗∗ p < 0.001 vs. 0 μg/mL; # p < 0.05, ## p < 0.01 vs. 250 μg/mL; n = 3 biological replicates). (F) Cell viability of H/R-treated BEAS-2B cells assessed by cell counting kit-8 (CCK-8) assay. Cells were treated with Rg3, PACVs, or Rg3@PACVs with or without near-infrared (NIR) irradiation. (G–I) Real-time quantitative polymerase chain reaction (RT-qPCR) analysis of inflammatory gene expression (IL-6, IL-1β, and TNF-α) in H/R-stimulated BEAS-2B cells under different pretreatment conditions. (J) Immunofluorescence showing expression and co-localization of NLRP3 (green) and COX2 (red) in H/R-injured lung epithelial cells. Nuclei stained with DAPI (blue). Scale bars, 100 μm. (K) Cell proliferation detected by bromodeoxyuridine <t>(BrdU)</t> staining (red) in the above epithelial cells. Nuclei stained with DAPI (blue). Scale bars, 50 μm. (L) Apoptosis ratio analyzed by flow cytometry using Annexin V-Allophycocyanin (Annexin V-APC) and 7-Aminoactinomycin D (7-AAD) staining. Data are presented as the mean ± SD and analyzed using one-way ANOVA (B–E and G–I) and two-way ANOVA (F) with Tukey’s post hoc test (∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001 vs. control; # p < 0.05, ## p < 0.01, ### p < 0.001 vs. H/R; & p < 0.05, && p < 0.01, &&& p < 0.001 vs. H/R + Rg3@PACVs; n = 3 biological replicates, for F–I).
    Rc112 Brdu Elisa Kit Servicebio, supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/brdu+elisa+kit/pm42030937-199-85-89?v=Servicebio+Inc
    Average 86 stars, based on 1 article reviews
    rc112 brdu elisa kit servicebio - by Bioz Stars, 2026-07
    86/100 stars
    		  Buy from Supplier
    brdu cell proliferation elisa kit  (Cell Signaling Technology Inc)
    86
    Cell Signaling Technology Inc brdu cell proliferation elisa kit
    Targeted repair of hypoxia/reoxygenation (H/R)-injured lung epithelial cells by Rg3@PACVs (A) Cellular uptake of Dio-labeled Rg3@PACVs (green) by H/R-injured BEAS-2B cells. Fluorescent localization was analyzed with or without pretreatment of endocytosis inhibitors (filipin, chlorpromazine, or chloroquine) (scale bars, 20 μm). (B–E) Cytokine adsorption capacity assessed by co-incubation of Rg3@PACVs (500 or 250 μg/mL) with inflammatory cytokines (IL-6, TNF-α, IL-1β, and CCL-2). Cytokine concentrations in supernatants were measured after centrifugation ( ∗∗∗ p < 0.001 vs. 0 μg/mL; # p < 0.05, ## p < 0.01 vs. 250 μg/mL; n = 3 biological replicates). (F) Cell viability of H/R-treated BEAS-2B cells assessed by cell counting kit-8 (CCK-8) assay. Cells were treated with Rg3, PACVs, or Rg3@PACVs with or without near-infrared (NIR) irradiation. (G–I) Real-time quantitative polymerase chain reaction (RT-qPCR) analysis of inflammatory gene expression (IL-6, IL-1β, and TNF-α) in H/R-stimulated BEAS-2B cells under different pretreatment conditions. (J) Immunofluorescence showing expression and co-localization of NLRP3 (green) and COX2 (red) in H/R-injured lung epithelial cells. Nuclei stained with DAPI (blue). Scale bars, 100 μm. (K) Cell proliferation detected by bromodeoxyuridine <t>(BrdU)</t> staining (red) in the above epithelial cells. Nuclei stained with DAPI (blue). Scale bars, 50 μm. (L) Apoptosis ratio analyzed by flow cytometry using Annexin V-Allophycocyanin (Annexin V-APC) and 7-Aminoactinomycin D (7-AAD) staining. Data are presented as the mean ± SD and analyzed using one-way ANOVA (B–E and G–I) and two-way ANOVA (F) with Tukey’s post hoc test (∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001 vs. control; # p < 0.05, ## p < 0.01, ### p < 0.001 vs. H/R; & p < 0.05, && p < 0.01, &&& p < 0.001 vs. H/R + Rg3@PACVs; n = 3 biological replicates, for F–I).
    Brdu Cell Proliferation Elisa Kit, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/brdu+elisa+kit/pm41832516-99-6-11?v=Cell+Signaling+Technology+Inc
    Average 86 stars, based on 1 article reviews
    brdu cell proliferation elisa kit - by Bioz Stars, 2026-07
    86/100 stars
    		  Buy from Supplier
    cytoselect brdu cell proliferation elisa kit  (Cell Biolabs Inc)
    86
    Cell Biolabs Inc cytoselect brdu cell proliferation elisa kit
    Targeted repair of hypoxia/reoxygenation (H/R)-injured lung epithelial cells by Rg3@PACVs (A) Cellular uptake of Dio-labeled Rg3@PACVs (green) by H/R-injured BEAS-2B cells. Fluorescent localization was analyzed with or without pretreatment of endocytosis inhibitors (filipin, chlorpromazine, or chloroquine) (scale bars, 20 μm). (B–E) Cytokine adsorption capacity assessed by co-incubation of Rg3@PACVs (500 or 250 μg/mL) with inflammatory cytokines (IL-6, TNF-α, IL-1β, and CCL-2). Cytokine concentrations in supernatants were measured after centrifugation ( ∗∗∗ p < 0.001 vs. 0 μg/mL; # p < 0.05, ## p < 0.01 vs. 250 μg/mL; n = 3 biological replicates). (F) Cell viability of H/R-treated BEAS-2B cells assessed by cell counting kit-8 (CCK-8) assay. Cells were treated with Rg3, PACVs, or Rg3@PACVs with or without near-infrared (NIR) irradiation. (G–I) Real-time quantitative polymerase chain reaction (RT-qPCR) analysis of inflammatory gene expression (IL-6, IL-1β, and TNF-α) in H/R-stimulated BEAS-2B cells under different pretreatment conditions. (J) Immunofluorescence showing expression and co-localization of NLRP3 (green) and COX2 (red) in H/R-injured lung epithelial cells. Nuclei stained with DAPI (blue). Scale bars, 100 μm. (K) Cell proliferation detected by bromodeoxyuridine <t>(BrdU)</t> staining (red) in the above epithelial cells. Nuclei stained with DAPI (blue). Scale bars, 50 μm. (L) Apoptosis ratio analyzed by flow cytometry using Annexin V-Allophycocyanin (Annexin V-APC) and 7-Aminoactinomycin D (7-AAD) staining. Data are presented as the mean ± SD and analyzed using one-way ANOVA (B–E and G–I) and two-way ANOVA (F) with Tukey’s post hoc test (∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001 vs. control; # p < 0.05, ## p < 0.01, ### p < 0.001 vs. H/R; & p < 0.05, && p < 0.01, &&& p < 0.001 vs. H/R + Rg3@PACVs; n = 3 biological replicates, for F–I).
    Cytoselect Brdu Cell Proliferation Elisa Kit, supplied by Cell Biolabs Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/brdu+elisa+kit/pm41417735-404-26-32?v=Cell+Biolabs+Inc
    Average 86 stars, based on 1 article reviews
    cytoselect brdu cell proliferation elisa kit - by Bioz Stars, 2026-07
    86/100 stars
    		  Buy from Supplier
    brdu cell proliferation enzyme-linked immunosorbent assay (elisa) kit  (Millipore)
    90
    Millipore brdu cell proliferation enzyme-linked immunosorbent assay (elisa) kit
    Targeted repair of hypoxia/reoxygenation (H/R)-injured lung epithelial cells by Rg3@PACVs (A) Cellular uptake of Dio-labeled Rg3@PACVs (green) by H/R-injured BEAS-2B cells. Fluorescent localization was analyzed with or without pretreatment of endocytosis inhibitors (filipin, chlorpromazine, or chloroquine) (scale bars, 20 μm). (B–E) Cytokine adsorption capacity assessed by co-incubation of Rg3@PACVs (500 or 250 μg/mL) with inflammatory cytokines (IL-6, TNF-α, IL-1β, and CCL-2). Cytokine concentrations in supernatants were measured after centrifugation ( ∗∗∗ p < 0.001 vs. 0 μg/mL; # p < 0.05, ## p < 0.01 vs. 250 μg/mL; n = 3 biological replicates). (F) Cell viability of H/R-treated BEAS-2B cells assessed by cell counting kit-8 (CCK-8) assay. Cells were treated with Rg3, PACVs, or Rg3@PACVs with or without near-infrared (NIR) irradiation. (G–I) Real-time quantitative polymerase chain reaction (RT-qPCR) analysis of inflammatory gene expression (IL-6, IL-1β, and TNF-α) in H/R-stimulated BEAS-2B cells under different pretreatment conditions. (J) Immunofluorescence showing expression and co-localization of NLRP3 (green) and COX2 (red) in H/R-injured lung epithelial cells. Nuclei stained with DAPI (blue). Scale bars, 100 μm. (K) Cell proliferation detected by bromodeoxyuridine <t>(BrdU)</t> staining (red) in the above epithelial cells. Nuclei stained with DAPI (blue). Scale bars, 50 μm. (L) Apoptosis ratio analyzed by flow cytometry using Annexin V-Allophycocyanin (Annexin V-APC) and 7-Aminoactinomycin D (7-AAD) staining. Data are presented as the mean ± SD and analyzed using one-way ANOVA (B–E and G–I) and two-way ANOVA (F) with Tukey’s post hoc test (∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001 vs. control; # p < 0.05, ## p < 0.01, ### p < 0.001 vs. H/R; & p < 0.05, && p < 0.01, &&& p < 0.001 vs. H/R + Rg3@PACVs; n = 3 biological replicates, for F–I).
    Brdu Cell Proliferation Enzyme Linked Immunosorbent Assay (Elisa) Kit, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/brdu+elisa+kit/10__1016_slash_j__sajb__2025__03__064-77-1-11?v=Millipore
    Average 90 stars, based on 1 article reviews
    brdu cell proliferation enzyme-linked immunosorbent assay (elisa) kit - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    colorimetric brdu cell proliferation elisa kit  (Merck KGaA)
    90
    Merck KGaA colorimetric brdu cell proliferation elisa kit
    Targeted repair of hypoxia/reoxygenation (H/R)-injured lung epithelial cells by Rg3@PACVs (A) Cellular uptake of Dio-labeled Rg3@PACVs (green) by H/R-injured BEAS-2B cells. Fluorescent localization was analyzed with or without pretreatment of endocytosis inhibitors (filipin, chlorpromazine, or chloroquine) (scale bars, 20 μm). (B–E) Cytokine adsorption capacity assessed by co-incubation of Rg3@PACVs (500 or 250 μg/mL) with inflammatory cytokines (IL-6, TNF-α, IL-1β, and CCL-2). Cytokine concentrations in supernatants were measured after centrifugation ( ∗∗∗ p < 0.001 vs. 0 μg/mL; # p < 0.05, ## p < 0.01 vs. 250 μg/mL; n = 3 biological replicates). (F) Cell viability of H/R-treated BEAS-2B cells assessed by cell counting kit-8 (CCK-8) assay. Cells were treated with Rg3, PACVs, or Rg3@PACVs with or without near-infrared (NIR) irradiation. (G–I) Real-time quantitative polymerase chain reaction (RT-qPCR) analysis of inflammatory gene expression (IL-6, IL-1β, and TNF-α) in H/R-stimulated BEAS-2B cells under different pretreatment conditions. (J) Immunofluorescence showing expression and co-localization of NLRP3 (green) and COX2 (red) in H/R-injured lung epithelial cells. Nuclei stained with DAPI (blue). Scale bars, 100 μm. (K) Cell proliferation detected by bromodeoxyuridine <t>(BrdU)</t> staining (red) in the above epithelial cells. Nuclei stained with DAPI (blue). Scale bars, 50 μm. (L) Apoptosis ratio analyzed by flow cytometry using Annexin V-Allophycocyanin (Annexin V-APC) and 7-Aminoactinomycin D (7-AAD) staining. Data are presented as the mean ± SD and analyzed using one-way ANOVA (B–E and G–I) and two-way ANOVA (F) with Tukey’s post hoc test (∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001 vs. control; # p < 0.05, ## p < 0.01, ### p < 0.001 vs. H/R; & p < 0.05, && p < 0.01, &&& p < 0.001 vs. H/R + Rg3@PACVs; n = 3 biological replicates, for F–I).
    Colorimetric Brdu Cell Proliferation Elisa Kit, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/brdu+elisa+kit/pm40332443-308-7-13?v=Merck+KGaA
    Average 90 stars, based on 1 article reviews
    colorimetric brdu cell proliferation elisa kit - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    brdu cell proliferation elisa kit  (Cell Biolabs Inc)
    90
    Cell Biolabs Inc brdu cell proliferation elisa kit
    Targeted repair of hypoxia/reoxygenation (H/R)-injured lung epithelial cells by Rg3@PACVs (A) Cellular uptake of Dio-labeled Rg3@PACVs (green) by H/R-injured BEAS-2B cells. Fluorescent localization was analyzed with or without pretreatment of endocytosis inhibitors (filipin, chlorpromazine, or chloroquine) (scale bars, 20 μm). (B–E) Cytokine adsorption capacity assessed by co-incubation of Rg3@PACVs (500 or 250 μg/mL) with inflammatory cytokines (IL-6, TNF-α, IL-1β, and CCL-2). Cytokine concentrations in supernatants were measured after centrifugation ( ∗∗∗ p < 0.001 vs. 0 μg/mL; # p < 0.05, ## p < 0.01 vs. 250 μg/mL; n = 3 biological replicates). (F) Cell viability of H/R-treated BEAS-2B cells assessed by cell counting kit-8 (CCK-8) assay. Cells were treated with Rg3, PACVs, or Rg3@PACVs with or without near-infrared (NIR) irradiation. (G–I) Real-time quantitative polymerase chain reaction (RT-qPCR) analysis of inflammatory gene expression (IL-6, IL-1β, and TNF-α) in H/R-stimulated BEAS-2B cells under different pretreatment conditions. (J) Immunofluorescence showing expression and co-localization of NLRP3 (green) and COX2 (red) in H/R-injured lung epithelial cells. Nuclei stained with DAPI (blue). Scale bars, 100 μm. (K) Cell proliferation detected by bromodeoxyuridine <t>(BrdU)</t> staining (red) in the above epithelial cells. Nuclei stained with DAPI (blue). Scale bars, 50 μm. (L) Apoptosis ratio analyzed by flow cytometry using Annexin V-Allophycocyanin (Annexin V-APC) and 7-Aminoactinomycin D (7-AAD) staining. Data are presented as the mean ± SD and analyzed using one-way ANOVA (B–E and G–I) and two-way ANOVA (F) with Tukey’s post hoc test (∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001 vs. control; # p < 0.05, ## p < 0.01, ### p < 0.001 vs. H/R; & p < 0.05, && p < 0.01, &&& p < 0.001 vs. H/R + Rg3@PACVs; n = 3 biological replicates, for F–I).
    Brdu Cell Proliferation Elisa Kit, supplied by Cell Biolabs Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/brdu+elisa+kit/pm40211119-77-16-23?v=Cell+Biolabs+Inc
    Average 90 stars, based on 1 article reviews
    brdu cell proliferation elisa kit - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    brdu cell proliferation elisa kit  (Funakoshi ltd)
    90
    Funakoshi ltd brdu cell proliferation elisa kit
    Targeted repair of hypoxia/reoxygenation (H/R)-injured lung epithelial cells by Rg3@PACVs (A) Cellular uptake of Dio-labeled Rg3@PACVs (green) by H/R-injured BEAS-2B cells. Fluorescent localization was analyzed with or without pretreatment of endocytosis inhibitors (filipin, chlorpromazine, or chloroquine) (scale bars, 20 μm). (B–E) Cytokine adsorption capacity assessed by co-incubation of Rg3@PACVs (500 or 250 μg/mL) with inflammatory cytokines (IL-6, TNF-α, IL-1β, and CCL-2). Cytokine concentrations in supernatants were measured after centrifugation ( ∗∗∗ p < 0.001 vs. 0 μg/mL; # p < 0.05, ## p < 0.01 vs. 250 μg/mL; n = 3 biological replicates). (F) Cell viability of H/R-treated BEAS-2B cells assessed by cell counting kit-8 (CCK-8) assay. Cells were treated with Rg3, PACVs, or Rg3@PACVs with or without near-infrared (NIR) irradiation. (G–I) Real-time quantitative polymerase chain reaction (RT-qPCR) analysis of inflammatory gene expression (IL-6, IL-1β, and TNF-α) in H/R-stimulated BEAS-2B cells under different pretreatment conditions. (J) Immunofluorescence showing expression and co-localization of NLRP3 (green) and COX2 (red) in H/R-injured lung epithelial cells. Nuclei stained with DAPI (blue). Scale bars, 100 μm. (K) Cell proliferation detected by bromodeoxyuridine <t>(BrdU)</t> staining (red) in the above epithelial cells. Nuclei stained with DAPI (blue). Scale bars, 50 μm. (L) Apoptosis ratio analyzed by flow cytometry using Annexin V-Allophycocyanin (Annexin V-APC) and 7-Aminoactinomycin D (7-AAD) staining. Data are presented as the mean ± SD and analyzed using one-way ANOVA (B–E and G–I) and two-way ANOVA (F) with Tukey’s post hoc test (∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001 vs. control; # p < 0.05, ## p < 0.01, ### p < 0.001 vs. H/R; & p < 0.05, && p < 0.01, &&& p < 0.001 vs. H/R + Rg3@PACVs; n = 3 biological replicates, for F–I).
    Brdu Cell Proliferation Elisa Kit, supplied by Funakoshi ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/brdu+elisa+kit/10__7554_slash_elife__98766-406-6-11?v=Funakoshi+ltd
    Average 90 stars, based on 1 article reviews
    brdu cell proliferation elisa kit - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Targeted repair of hypoxia/reoxygenation (H/R)-injured lung epithelial cells by Rg3@PACVs (A) Cellular uptake of Dio-labeled Rg3@PACVs (green) by H/R-injured BEAS-2B cells. Fluorescent localization was analyzed with or without pretreatment of endocytosis inhibitors (filipin, chlorpromazine, or chloroquine) (scale bars, 20 μm). (B–E) Cytokine adsorption capacity assessed by co-incubation of Rg3@PACVs (500 or 250 μg/mL) with inflammatory cytokines (IL-6, TNF-α, IL-1β, and CCL-2). Cytokine concentrations in supernatants were measured after centrifugation ( ∗∗∗ p < 0.001 vs. 0 μg/mL; # p < 0.05, ## p < 0.01 vs. 250 μg/mL; n = 3 biological replicates). (F) Cell viability of H/R-treated BEAS-2B cells assessed by cell counting kit-8 (CCK-8) assay. Cells were treated with Rg3, PACVs, or Rg3@PACVs with or without near-infrared (NIR) irradiation. (G–I) Real-time quantitative polymerase chain reaction (RT-qPCR) analysis of inflammatory gene expression (IL-6, IL-1β, and TNF-α) in H/R-stimulated BEAS-2B cells under different pretreatment conditions. (J) Immunofluorescence showing expression and co-localization of NLRP3 (green) and COX2 (red) in H/R-injured lung epithelial cells. Nuclei stained with DAPI (blue). Scale bars, 100 μm. (K) Cell proliferation detected by bromodeoxyuridine (BrdU) staining (red) in the above epithelial cells. Nuclei stained with DAPI (blue). Scale bars, 50 μm. (L) Apoptosis ratio analyzed by flow cytometry using Annexin V-Allophycocyanin (Annexin V-APC) and 7-Aminoactinomycin D (7-AAD) staining. Data are presented as the mean ± SD and analyzed using one-way ANOVA (B–E and G–I) and two-way ANOVA (F) with Tukey’s post hoc test (∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001 vs. control; # p < 0.05, ## p < 0.01, ### p < 0.001 vs. H/R; & p < 0.05, && p < 0.01, &&& p < 0.001 vs. H/R + Rg3@PACVs; n = 3 biological replicates, for F–I).

    Journal: Cell Reports Medicine

    Article Title: Macrophage-mimetic photothermal nanotherapeutics regulate mitochondrial homeostasis and inflammatory cascades in lung ischemia-reperfusion injury

    doi: 10.1016/j.xcrm.2026.102768

    Figure Lengend Snippet: Targeted repair of hypoxia/reoxygenation (H/R)-injured lung epithelial cells by Rg3@PACVs (A) Cellular uptake of Dio-labeled Rg3@PACVs (green) by H/R-injured BEAS-2B cells. Fluorescent localization was analyzed with or without pretreatment of endocytosis inhibitors (filipin, chlorpromazine, or chloroquine) (scale bars, 20 μm). (B–E) Cytokine adsorption capacity assessed by co-incubation of Rg3@PACVs (500 or 250 μg/mL) with inflammatory cytokines (IL-6, TNF-α, IL-1β, and CCL-2). Cytokine concentrations in supernatants were measured after centrifugation ( ∗∗∗ p < 0.001 vs. 0 μg/mL; # p < 0.05, ## p < 0.01 vs. 250 μg/mL; n = 3 biological replicates). (F) Cell viability of H/R-treated BEAS-2B cells assessed by cell counting kit-8 (CCK-8) assay. Cells were treated with Rg3, PACVs, or Rg3@PACVs with or without near-infrared (NIR) irradiation. (G–I) Real-time quantitative polymerase chain reaction (RT-qPCR) analysis of inflammatory gene expression (IL-6, IL-1β, and TNF-α) in H/R-stimulated BEAS-2B cells under different pretreatment conditions. (J) Immunofluorescence showing expression and co-localization of NLRP3 (green) and COX2 (red) in H/R-injured lung epithelial cells. Nuclei stained with DAPI (blue). Scale bars, 100 μm. (K) Cell proliferation detected by bromodeoxyuridine (BrdU) staining (red) in the above epithelial cells. Nuclei stained with DAPI (blue). Scale bars, 50 μm. (L) Apoptosis ratio analyzed by flow cytometry using Annexin V-Allophycocyanin (Annexin V-APC) and 7-Aminoactinomycin D (7-AAD) staining. Data are presented as the mean ± SD and analyzed using one-way ANOVA (B–E and G–I) and two-way ANOVA (F) with Tukey’s post hoc test (∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001 vs. control; # p < 0.05, ## p < 0.01, ### p < 0.001 vs. H/R; & p < 0.05, && p < 0.01, &&& p < 0.001 vs. H/R + Rg3@PACVs; n = 3 biological replicates, for F–I).

    Article Snippet: BrdU ELISA kit , Servicebio , Cat# GC310002.

    Techniques: Labeling, Adsorption, Incubation, Centrifugation, Cell Counting, CCK-8 Assay, Irradiation, Real-time Polymerase Chain Reaction, Quantitative RT-PCR, Gene Expression, Immunofluorescence, Expressing, Staining, BrdU Staining, Flow Cytometry, Control